Case Reports
doi: 10.1016/j.jvir.2009.03.011.
Epub 2009 May 5.
Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery
Affiliations
- PMID: 19406668
- DOI: 10.1016/j.jvir.2009.03.011
Item in Clipboard
Case Reports
Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery
J Vasc Interv Radiol.
2009 Jun.
Abstract
The most common use of radioembolization is in the treatment of primary and secondary liver tumors, and the most common radioisotope used is yttrium-90. This form of therapy has been proven to be successful in achieving tumor reduction and prolonging survival. Adverse events, although uncommon and usually self-limiting, have been reported. The present report describes a case of radiation dermatitis caused by shunting of (90)Y microspheres to the anterior abdominal wall via a patent falciform artery. When identified, prophylactic embolization of this patent artery may prevent the potential adverse event of radiation-induced dermatitis after radioembolization.
Similar articles
-
Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.Chin Med J (Engl). 1999 May;112(5):430-2. Chin Med J (Engl). 1999. PMID: 11593513
-
Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):792-800. doi: 10.1016/j.ijrobp.2006.05.065. Epub 2006 Aug 14. Int J Radiat Oncol Biol Phys. 2006. PMID: 16904840
-
Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review.J Vasc Interv Radiol. 2009 Sep;20(9):1121-30; quiz 1131. doi: 10.1016/j.jvir.2009.05.030. Epub 2009 Jul 29. J Vasc Interv Radiol. 2009. PMID: 19640737 Review.
-
Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.Dig Dis. 2009;27(2):189-99. doi: 10.1159/000218352. Epub 2009 Jun 22. Dig Dis. 2009. PMID: 19546558
-
Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.Future Oncol. 2007 Feb;3(1):73-81. doi: 10.2217/14796694.3.1.73. Future Oncol. 2007. PMID: 17280504 Review.
Cited by
-
Non Target Shunting of Tc-99m Macroaggregates of Albumin and Radiolabeled Yttrium-90 Microspheres into Hepatic Falciform Artery - Less Observed Arterial Variant not to be Overlooked.Indian J Nucl Med. 2023 Jul-Sep;38(3):286-288. doi: 10.4103/ijnm.ijnm_196_22. Epub 2023 Oct 10. Indian J Nucl Med. 2023. PMID: 38046965 Free PMC article.
-
The Role of Catheter-Directed CT-Angiography in Radioembolisation.Cardiovasc Intervent Radiol. 2022 Nov;45(11):1651-1658. doi: 10.1007/s00270-022-03157-4. Epub 2022 May 20. Cardiovasc Intervent Radiol. 2022. PMID: 35595985 Review.
-
Recognizing and Managing Adverse Events in Y-90 Radioembolization.Semin Intervent Radiol. 2021 Oct;38(4):453-459. doi: 10.1055/s-0041-1735617. Epub 2021 Oct 7. Semin Intervent Radiol. 2021. PMID: 34629713 Free PMC article. Review.
-
Improved image quality in abdominal CT in patients who underwent treatment for hepatocellular carcinoma with small metal implants using a raw data-based metal artifact reduction algorithm.Eur Radiol. 2017 Jul;27(7):2978-2988. doi: 10.1007/s00330-016-4660-4. Epub 2016 Dec 2. Eur Radiol. 2017. PMID: 27913913
-
Identification of novel peptoid agonists of fibroblast growth factor receptor using microarray-based screening.Medchemcomm. 2016;7:1183-1189. doi: 10.1039/C6MD00121A. Epub 2016 Apr 14. Medchemcomm. 2016. PMID: 27721968 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
